PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Pharvaris N.V.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Apr 2, 2026
$29.77+2.03 (+7.32%)
Close on Oct 19, 2026
Share price
+$8.65 (+40.96%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- EPS, diluted
- -2.97 EUR
- Free cash flow
- -€137.24M
- Diluted shares
- 68M
Valuation needs the share price. It fills in once daily prices are connected and converted from EUR.
Nine years at a glance
Fiscal years 2017 to 2025, EUR
Operating income
-€173.71M
Net income
–
EPS, diluted
-2.97 EUR
Free cash flow
-€137.24M
Reported period